Exponent Inc
NASDAQ:EXPO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
65.27
95.43
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Exponent Inc
In the world of engineering and scientific consulting, Exponent Inc. has carved out a reputation for providing critical insights across a wide array of industries. Founded in 1967, the company has become a beacon for addressing complex technical issues and solving challenging problems. Exponent operates through its network of highly specialized professionals, including engineers, scientists, and other technical experts who bring their expertise to bear on some of the most intricate challenges facing industries today. The company's work often involves providing consultancy on failure analysis, regulatory compliance, and risk management, which are essential services for the automotive, energy, electronics, and healthcare sectors, among others.
Exponent's business model revolves around building a deep, intrinsic value through its specialized services — leveraging human intellect to guide companies in decision-making, problem-solving, and navigating regulations. This focus on intellectual capital allows Exponent to charge premium fees for their services, serving clients that require the highest level of scientific and engineering rigor to solve pressing problems or to prevent them. The firm's ability to deploy teams globally ensures it's on the pulse of cutting-edge developments and can deliver insights where and when they are most needed. By marrying science with business acumen, Exponent maintains a steady flow of revenue through both project consulting and expert witness services in litigation, further solidifying its role as an indispensably strategic partner for Fortune 500 companies and leading global enterprises.
In the world of engineering and scientific consulting, Exponent Inc. has carved out a reputation for providing critical insights across a wide array of industries. Founded in 1967, the company has become a beacon for addressing complex technical issues and solving challenging problems. Exponent operates through its network of highly specialized professionals, including engineers, scientists, and other technical experts who bring their expertise to bear on some of the most intricate challenges facing industries today. The company's work often involves providing consultancy on failure analysis, regulatory compliance, and risk management, which are essential services for the automotive, energy, electronics, and healthcare sectors, among others.
Exponent's business model revolves around building a deep, intrinsic value through its specialized services — leveraging human intellect to guide companies in decision-making, problem-solving, and navigating regulations. This focus on intellectual capital allows Exponent to charge premium fees for their services, serving clients that require the highest level of scientific and engineering rigor to solve pressing problems or to prevent them. The firm's ability to deploy teams globally ensures it's on the pulse of cutting-edge developments and can deliver insights where and when they are most needed. By marrying science with business acumen, Exponent maintains a steady flow of revenue through both project consulting and expert witness services in litigation, further solidifying its role as an indispensably strategic partner for Fortune 500 companies and leading global enterprises.
Revenue Growth: Exponent delivered double-digit net revenue growth in Q3 2025, with net revenues up 10% year-over-year to $137.1 million.
Profit & Margins: Net income rose to $28 million ($0.55 per share), and EBITDA grew 9% to $38.8 million, though EBITDA margin dipped slightly due to one-time meeting expenses.
Guidance & Outlook: Management maintained revenue guidance and raised margin expectations for full-year 2025, despite a Q4 headwind from fewer workdays.
Business Drivers: Strong demand in dispute-related (reactive) work across energy, transportation, life sciences, and construction; proactive work steady, but consumer electronics showing improving trends.
AI & Innovation: Artificial intelligence is increasingly integrated across projects and industries, driving both reactive and proactive engagements.
Stock Buyback: Board approved a $100 million increase in the share buyback program, reflecting confidence in long-term growth.
Hiring & Talent: Headcount grew 3% in Q3; management targets 4–6% growth for 2026 as demand remains strong, especially in digital health and automation.
